Program Summary
Day I Friday, MAY 26 2023
Friday, MAY 26 | Topic | Name | Supported by |
09:00 - 09:05 | Opening and Introductory Remarks | W. Kuczyński, N. Rahman, M. Szamatowicz, S. Wołczyński | |
09:05 - 09:15 | Few words on the Polish Reproductive Medicine Cluster | ||
Plenary Session
Chairs: W. Kuczyński, S. Wołczyński |
|||
09:15 - 09:45 | Opening talk from the ESHRE CHAIR: Quo vadis ART in Europe - The Differences and common strands we see | ||
09:45 - 10:15 | Deep endometriosis with and without colorectal involvement : role of robotic surgery | ||
Session 1. New aspects in Reproductive Medicine
Chairs: R. Kurzawa, I. Szymusik |
|||
10:10 - 10:35 | Safety and efficacy of corifollitropin alfa (CFA) in low responders in ART | ||
10:35 - 11:00 | 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor for the treatment of endometriosis | ||
11:00 - 11:25 | Efficacy and safety of follitropin alfa/lutropin alfa in ART in poor ovarian responders | ||
11:25 - 12:00 | Coffee Break | ||
Session 2. Oocytes and embryo
Chairs: K. Kozioł, K. Łukaszuk, J. Szamtowicz |
|||
12:00 - 12:25 | Oocyte freezing: a valuable clinical and social tool | ||
12:25 - 12:50 | Embryo Genome Editing | ||
Session 3. Future of IVF in Europe - round Table meeting Former and present Chairs of ESHRE Chairs: R. Spaczyński, N. Rahman |
|||
12:50 - 14:20 | 1. MAR today: The scenarios. | ||
1.1 How to organize an infertility prevention program for medical and social indications – Juha Tupanainen | |||
1.2 Basic research: a tool for the advance of ART? – Anna Veiga | |||
1.3 Add-ons: lab – Kersti Lundin | |||
1.4 Add-ons: clinic – Luca Gianaroli | |||
2. The ESHRE contribution. | |||
2.1 Insight into the proposed EU regulation – Cristina Magli | |||
2.2 ESHRE collaboration/support including ART registry – Carlos Calhaz-Jorge | |||
3. Time for Q&A from Audience and earlier received questions | |||
14:20 - 15:20 | Lunch | ||
Session 4. Reproductive Medicine advancements
Chairs: B. Banaszewska, A.Kuczyńska |
|||
15:20 - 15:45 | Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom? | ||
15:45 - 16:10 | Subcutaneous versus vaginal progesterone for vitrified-warmed blastocyst transfer in artificial cycles | ||
Session 5. Embryo, blastocyst
Chairs: G. Polak, B. Chrostowski |
|||
16:10 - 16:35 | Is double embryo transfer already history? | ||
16:35 - 17:00 | Debate: Blastocyst transfer or Cleavage stage transfer? | ||
17:00 - 17:20 | Coffe Brake | ||
Session 6. hCG and progesterone Chairs: W. Baranowski, J. Kubiak |
|||
17:20 - 17:45 | Divergent Roles of Sirtuin 1 In Human Granulosa Cells |
|
|
17:45 - 18:10 | Subcutaneous adipose tissue as a therapeutic target in PCOS |
Day II Saturday, MAY 27 2023
Saturday, MAY 27 | Topic | Name | Supported by |
Session 7. Medycyna translacyjna Chairs: W. Baranowski, W.Kuczyński |
|||
09:00 - 09:20 | Translacyjna medycyna rozrodu | ||
09:20 - 09:40 | Molecular mechanisms regulating the timing of the first two cell divisions of the embryo | ||
09:40 - 10:00 | Maternal microbiome and its role in the regulation of immune balance at the fetomaternal interface | ||
10:20 - 10:40 | Co nowego w przewidywaniu potencjału rozwojowego zarodków? | ||
10:40 - 11:00 | Coffee Break | ||
Session 8. Endometrioza
Chairs: J. Szamatowicz, I. Szymusik |
|||
11:10 - 11:30 | Wpływ endometriozy na płodność i leczenie | ||
11:30 - 11:50 | Druga faza u pacjentek z endometrioza | ||
11:50 - 12:10 | IVF u kobiety z endometriozą | ||
12:10 - 12:30 | Dyskusja | ||
Session 9. Technologie w medycynie rozrodu
Chairs: A. Wdowiak, K. Kozioł |
|||
12:30 - 12:50 | USG piersi w medycynie rozrodu. Czy to w ogóle potrzebne badanie? | ||
12:50 - 13:10 | Czy jest miejsce dla laparoskopii i histeroskopii w nowoczesnych ART? | ||
13:10 - 13:30 | Rola standaryzacji badań obrazowych w IVF | ||
13:30 - 14:30 | Lunch | ||
Session 10. Poznajmy się. Prezentacje młodych naukowców. 10-minutowe wystapienia Chairs:A. Kuczyńska, N. Rahman |
|||
14:30 - 14:50 | Novel uterine leiomyoma biomimetic models: Why 3D? | ||
14:50 - 15:10 | Molecular insights underlying the adverse effects of bisphenol A on reproductive health | Ewelina Palak | |
15:10 - 15:30 | Do insulin resistance and lifestyle affect male fertility? | ||
Session 11. Debata „Kim jest Twoja pacjentka?”
Michał Radwan, Iwona Szymusik, Robert Spaczyński, Katarzyna Kozioł, Beata Banaszewska, Marian Szamatowicz |
|||
15:30 - 16:30 | -indywidulaizacja postępowania w medycynie rozrodu | ||
- co wynika z badań hormonalnych | |||
- co wynika z badań obrazowych | |||
Zakończenie Konferencji
Nafis Rahman, Slawomir Wołczyński, Waldermar Kuczyński |
*The conference organizers stipulate that the program can be changed.